Clinical Trials Browser

Phase 2 × Lymphoma, Large B-Cell, Diffuse × AZD 6244 × Clear all

NCT01278615 2016-02-03

Selumetinib in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Phase 2 Terminated

16 enrolled 9 charts

Lymphoma, Large B-Cell, Diffuse